Fany K Segura-López1, Francisco Avilés-Jiménez2, Alfredo Güitrón-Cantú3, Hilda A Valdéz-Salazar2, Samuel León-Carballo4, Leoncio Guerrero-Pérez5, James G Fox6, Javier Torres2. 1. Departamento de Anestesiología, UMAE 71 IMSS, Torreón, Coahuila, México. 2. Unidad de Investigación en Enfermedades Infecciosas, UMAE Pediatría, IMSS, México City, DF, México. 3. Departamento de Endoscopía Digestiva, UMAE 71 IMSS, Torreón, Coahuila, México. 4. Departamento de Endoscopía Digestiva, ISSSTECH, Tuxtla Gutiérrez, Chiapas, México. 5. Departamento de Endoscopía Digestiva, HGZ No. 35 IMSS, Juarez, Chihuahua, México. 6. Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.
Abstract
BACKGROUND AND AIMS: The biliary tract cancer or cholangiocarcinoma (CCA) represents the sixth leading cause of gastrointestinal tumors in the Western world, and mortality varies across the world, with regions such as Chile, Thailand, Japan, and northeastern India presenting the highest rates. CCA may develop in the bile duct, gallbladder, or ampulla of Vater; and risk factors include obesity, parity, genetic background, geographical and environmental factors. Inflammation induced by bacterial infections might play a role in the pathogenesis of CCA. In this work, we investigated whether there is an association between extrahepatic cholangiocarcinoma (ECCA) and infection with S. typhi, H. hepaticus, or H. bilis in a Mexican population. METHODS: A total of 194 patients were included and divided into 91 patients with benign biliary pathology (controls) and 103 with ECCA (cases). Tumor samples were taken during endoscopic retrograde cholangiopancreatography by biliary brushing, followed by DNA extraction and PCR testing for infections. RESULTS: We found that 44/103 cases were positive for H. bilis, compared with 19/91 controls (p = 0.002; OR 2.83, 95% CI 1.49-5.32), and when analyzed by sub-site, H. bilis infection was significantly more associated with cancer in the common bile duct (p = 0.0005; OR 3.56, 95% CI 1.77-7.17). In contrast, H. hepaticus infection was not different between cases (17/103) and controls (13/91) (p = 0.82; OR 1.19, 95% CI 0.54-2.60). None of the samples were positive for S. typhi infection. CONCLUSION: In conclusion, infection with H. bilis but neither H. Hepaticus nor S. typhi was significantly associated with ECCA, particularly with tumors located in the common bile duct.
BACKGROUND AND AIMS: The biliary tract cancer or cholangiocarcinoma (CCA) represents the sixth leading cause of gastrointestinal tumors in the Western world, and mortality varies across the world, with regions such as Chile, Thailand, Japan, and northeastern India presenting the highest rates. CCA may develop in the bile duct, gallbladder, or ampulla of Vater; and risk factors include obesity, parity, genetic background, geographical and environmental factors. Inflammation induced by bacterial infections might play a role in the pathogenesis of CCA. In this work, we investigated whether there is an association between extrahepatic cholangiocarcinoma (ECCA) and infection with S. typhi, H. hepaticus, or H. bilis in a Mexican population. METHODS: A total of 194 patients were included and divided into 91 patients with benign biliary pathology (controls) and 103 with ECCA (cases). Tumor samples were taken during endoscopic retrograde cholangiopancreatography by biliary brushing, followed by DNA extraction and PCR testing for infections. RESULTS: We found that 44/103 cases were positive for H. bilis, compared with 19/91 controls (p = 0.002; OR 2.83, 95% CI 1.49-5.32), and when analyzed by sub-site, H. bilisinfection was significantly more associated with cancer in the common bile duct (p = 0.0005; OR 3.56, 95% CI 1.77-7.17). In contrast, H. hepaticus infection was not different between cases (17/103) and controls (13/91) (p = 0.82; OR 1.19, 95% CI 0.54-2.60). None of the samples were positive for S. typhiinfection. CONCLUSION: In conclusion, infection with H. bilis but neither H. Hepaticus nor S. typhi was significantly associated with ECCA, particularly with tumors located in the common bile duct.
Authors: Zeli Shen; Yan Feng; Alexander Sheh; Jeffrey Everitt; Frederick Bertram; Bruce J Paster; James G Fox Journal: J Med Microbiol Date: 2015-06-30 Impact factor: 2.472
Authors: Mark T Whary; Chuanwu Wang; Catherine F Ruff; Mallory J DiVincenzo; Caralyn Labriola; Lillian Ge; Yan Feng; Zhongming Ge; Vasu Bakthavatchalu; Suresh Muthupalani; Bruce H Horwitz; James G Fox Journal: Comp Med Date: 2020-04-29 Impact factor: 0.982
Authors: Roseanna C Wheatley; Elaine Kilgour; Timothy Jacobs; Angela Lamarca; Richard A Hubner; Juan W Valle; Mairéad G McNamara Journal: Br J Cancer Date: 2021-10-18 Impact factor: 9.075
Authors: Stephanie E Woods; Courtney Ek; Zeli Shen; Yan Feng; Zhongming Ge; Sureshkumar Muthupalani; Mark T Whary; James G Fox Journal: Helicobacter Date: 2015-09-08 Impact factor: 5.753